先瑞达医疗科技控股有限公司于2026年3月2日公布了截至2026年2月28日的股份变动月报表。本次报告显示，公司于报告期内并未发生新增发行、购回或库藏股变动，各项股本数据保持不变。
报告显示，公司法定注册股本维持10,000,000,000股，面值每股USD 0.00001，总额USD 100,000；已发行股份数量为313,389,171股，较上月底无任何增减，同时并未设立或持有库藏股份。
公司在报告期内未涉及任何股份期权或其他股权激励计划的股份变动，也未进行任何购回或注销活动。月底合计已发行股份继续维持在313,389,171股。
截至2026年2月28日，公司确认符合香港联交所要求的公众持股量标准，并声明在本月所有股份相关事宜均已遵守适用的上市规则、法律及其他监管规定。公告由董事李静签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.